Edwards Lifesciences’ artificial aortic valve technology opens the way for innovative heart surgery, which promises to reduce costs, as well as patient recovery time.
Sr. Research Analyst
Sands Capital (2017-2018)
Arlington, VA Sr. Research Analyst, Associate Director of Research
Sands Capital (2009-2016)
Arlington, VA Research Analyst, Associate Director of Research
Sands Capital (2007-2009)
Arlington, VA Research Associate
SNL Financial (2006-2007)
Charlottesville, VA Analyst
University of Maryland - MBA, Robert H. Smith School of Business (2011)
University of Virginia - BA, Economics (2006)
Sands Capital is an active, long-term investor in leading innovative businesses globally. Our approach combines rigorous fundamental analysis with creative thinking to identify high-quality growth businesses that are creating the future. Through strategies designed to concentrate investment in these businesses, we serve the long-term growth objectives of institutions and fund sponsors in more than 40 countries.
An independent, staff-owned firm based in the Greater Washington, DC area, Sands Capital managed more than USD $68 billion in client assets as of December 31, 2020.
© 2021 Sands Capital Management. All Rights Reserved.
For institutional and professional investors only.